United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c belgium - 30g tube - ointment - 0.05% - skin-topical corticosteroids

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - diprolene® ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. diprolene ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on diprolene ointment use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that diprolene ointment may increase the risk of having a low birthweight infant and to use diprolene ointment on the smallest area of skin and for the shortest duration possible. in animal reproduction studies, increased malformations, including umbilical he

United States - English - NLM (National Library of Medicine)

organon llc - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - diprolene® ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. diprolene ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on diprolene ointment use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that diprolene ointment may increase the risk of having a low birthweight infant and to use diprolene ointment on the smallest area of skin and for the shortest duration possible. in animal reproduction studies, increased malformations, including umbilical he

Canada - English - Health Canada

organon canada inc. - betamethasone (betamethasone dipropionate) - ointment - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 ml - diprolene® lotion is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. diprolene lotion is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on diprolene lotion use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that diprolene lotion may increase the risk of having a low birthweight infant and to use diprolene lotion on the smallest area of skin and for the shortest duration possible. in animal reproduction studies, increased malformations, including umbilical hernias, ceph

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - diprolene® af cream is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. diprolene af cream is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on diprolene af cream use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that diprolene af cream may increase the risk of having a low birthweight infant and to use diprolene af cream on the smallest area of skin and for the shortest duration possible. in animal reproduction studies, increased malformations, including umbilical he

Canada - English - Health Canada

mylan pharmaceuticals ulc - clobetasol propionate - ointment - 0.05% - clobetasol propionate 0.05% - anti-inflammatory agents

Canada - English - Health Canada

taro pharmaceuticals inc - mometasone furoate - ointment - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents

Canada - English - Health Canada

merck canada inc - betamethasone (betamethasone dipropionate) - cream - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents

Canada - English - Health Canada

merck canada inc - betamethasone (betamethasone dipropionate) - lotion - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents